FDA approves device to treat AD/HD FDA, AD/HD 치료용 기기 승인
FDA approves device to treat AD/HD USA Today (4/20, Garrison) reported that on Friday, the FDA “announced…that it permitted marketing for the first medical device to treat” attention-deficit/hyperactivity disorder (AD/HD). Known as “the Monarch external Trigeminal Nerve Stimulation (eTNS) System, … Continued